Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-08-24Clinical Trial Update: EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]
This is a Phase 2 clinical trial from Sun Yat-sen University evaluating EBV lytic reactivation therapy together with a PD-1 antibody for rec…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating toripalimab with induction chemotherapy and radiation therapy including omega-3 for locally advanced nasop…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA [Phase 3]
A Phase III trial investigating post-radiation detectable plasma EBV DNA in nasopharyngeal carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients [NA]
A completed clinical trial evaluating whether epigallocatechin gallate (EGCG) influences Epstein-Barr virus reactivation in patients in remi…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma
A clinical trial update describes screening nasopharyngeal carcinoma using dual-energy CT combined with nasopharyngeal endoscopy; the study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPC [Phase 3]
Phase 3 trial update comparing tislelizumab plus GX versus tislelizumab plus GP in relapsed/refractory nasopharyngeal carcinoma is currently…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial evaluating intensity-modulated radiotherapy (IMRT) with lobaplatin-based concurrent chemoradiation for nasopharyngeal carcin…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating carbon ion radiotherapy (3 GyE per fraction) for locally recurrent nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal Carcinoma [Phase 2]
A phase 2 study is evaluating whether prophylactic neck irradiation can be omitted in nasopharyngeal carcinoma when toripalimab is given in …
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma
Clinical trial examining a watch-and-wait strategy after immunochemotherapy for locally recurrent nasopharyngeal carcinoma; recruitment has …
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC [Phase 2]
A Phase 2 clinical trial assessing the combination of QL1706 (Iparomlimab/Tuvorlimab) with a modified TPF induction regimen for locally adva…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial investigating the effect of nutritional management on patients with nasopharyngeal carcinoma undergoing concurrent ch…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity [Phase 3]
A phase 3 clinical trial update describing a protocol to shrink the anterior border of the CTV2 target volume in nasopharyngeal carcinoma to…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: An International Study on Pediatric Patients With Rare Tumors.
An international pediatric clinical trial study focused on rare tumors is currently recruiting, covering multiple tumor types.
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating Ivonescimab in combination with chemoradiotherapy for high-risk locoregionally advanced nasopharyngeal c…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial investigated combining nivolumab with chemoradiotherapy while omitting cisplatin in nasopharyngeal carcinoma; the study has …
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating PD-1 blockade with de-intensified chemoradiotherapy that spares concurrent cisplatin in Nasopharyngeal Car…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy [Phase 2]
A Phase 2 trial investigating the combination of tislelizumab and capecitabine for nasopharyngeal carcinoma with residual EBV DNA after radi…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial reports on the safety, tolerability, pharmacokinetics, and pharmacodynamics of INCB099280 in participants with advanced s…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating toripalimab in combination with radiotherapy for oligometastatic nasopharyngeal carcinoma, currently recru…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Neoadjuvant Therapy of GP Chemotherapy Combined With Tislelizumab in Locoregionally Advanced NPC [Phase 2]
Phase 2 neoadjuvant trial evaluating GP chemotherapy plus tislelizumab in locoregionally advanced nasopharyngeal carcinoma. The study status…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Adjuvant vs Surgery Only in Early-stage Recurrent NPC [Phase 3]
A Phase 3 clinical trial comparing adjuvant therapy versus surgery alone for early-stage recurrent nasopharyngeal carcinoma is currently rec…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC [Phase 2]
Phase 2 clinical trial evaluating two-cycle and three-cycle induction therapy with a modified TPF chemotherapy regimen plus Camrelizumab for…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy [Phase 2]
A Phase 2 clinical trial evaluating the combination of SBRT with Nimotuzumab and Tislelizumab for oligoprogressive recurrent/metastatic naso…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients [NA]
A clinical trial is evaluating whether vitamin D supplementation influences therapeutic response in nasopharyngeal carcinoma patients treate…